re: call your shot(s); winners for 2026

My big three are all nicely up today. This could turn out to be my best two day stretch dollar wise in years. All have been holds.

and VITAX where my actual money is is at ATHs. Most welcome development a year into retirement with no income

I've used PATHs software and it was not great....also difficult to find many use cases. Claude going to eat their lunch.

If it’s a tool then their revenues should be dropping or being nonrenewed. I don’t see that in their statements.

I think Wall Street is underestimating the amount of companies that wants to “code their own systems”, if the platform they already have is working fine.

For instance perhaps Anthropic’s products could be programmed to replicate what PATH does, but do you really want to hire a team to implement it or build it out if you already like PATH?

quote:

---

the companies getting big runs right now are all being rated or rerated as do-it-all AI platforms (aka business intelligence) and PATH is still seen as a tool.

---

n8n is the same thing... and its FREE. LINK


Also microsoft, google, snow, dynatrace, amazon, all have literally clones of this type of automation. I would only own this as a buyout opportunity.

and they haven’t and they are just stacking cash which tells me they are using that cash as insurance and not trying to get customers or innovate past service software. I know that maestro is supposed to be that but…when?

My theory on PATH is dead. I thought PATH would be a leader in agentic AI. I now think they were passed by. Claude Code / Claude Cowork / others are all providing better agentic AI than PATH bc they’re easier to use

quote:

---

NBIS has been huge and the rest of the year could be big, too...

---

I have a feeling 400 could be well within reach with one big deal and an ARR raise from 7-9bn to 8-10bn.

Toward the end of this year, 2027 ARR will be given (which would provide that final catapult above $400).

Because execution has actually been happening (our big bet all along), the market is sizing NBIS into its 2026 ARR.
So it’s being rewarded with a 7x multiple on the mid range of 8bn.

We could get more technical and factory in the subs, which would make that multiple much lower! But let’s keep it simple.

I think there’s room to expand into a 10x on ARR with an anthropic deal or equivalent. 80bn cap.
Raise ARR, 90bn cap.

I won’t guess what 2027 ARR will be…

So there’s room for expansion to 90bn this year.
90-57=33
33/57=0.579
231x.579=133.749
231+133=364

$364 is my logical base case before the announcement of 2027 ARR in Q4

The momentum play of the week could be a lesser known company called ELMT.

Loading Twitter/X Embed...
If tweet fails to load, click here.

You did better than me.
I was not gonna chase above $19

Looking at ASAN, CGNT today